Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and related derivatives

Molecules

Volumn 15, Issue 4, 2010, Pages 2526-2550

  Al Omar, Mohamed A ^a   Al Abdullah, Ebtehal S ^a   Shehata, Ihsan A ^a   Habib, Elsayed E ^b   Ibrahim, Tarek M ^b   El Emam, Ali A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

1,2,4 triazoles; 1 adamantyl derivatives; Antiinflammatory activity; Antimicrobial activity

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; BACTERIUM; CANDIDA ALBICANS; CANDIDA TROPICALIS; DRUG EFFECT; MALE; RAT; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; BACTERIA; CANDIDA ALBICANS; CANDIDA TROPICALIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRIAZOLES;

EID: 77951870387     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15042526     Document Type: Article

References (37)

1. Togo, Y.; Hornick, R.B.; Dawkins, A.T. Studies on induced influenza in man. I. Double blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against A2/Rockville/1/65 strain. J. Am. Med. Assoc. 1968, 203, 1089-1094.
2. Vernier, V.G.; Harmon, J.B.; Stump, J.M.; Lynes, T.L.; Marvel, M.P.; Smith, D.H. The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol. Appl. Pharmacol. 1969, 15, 642-665.
3. Hayden, F.G.; Gwaltney, J.M.I.; Van, C.R.L.; Adam, K.F.; Giordani, B. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adaults. Antimicrob. Agents Chemother. 1981, 19, 226-233.
4. Van Derpoorten, K.; Balzarini, J.; De Clercq, E.; Poupaert, J.H. Anti-HIV activity of N-1adamantyl-4-aminophthalimide. Biomed. Pharmacother. 1997, 51, 464-468.
5. Burstein, M.E.; Serbin, A.V.; Khakhulina, T.V.; Alymova, I.V.; Stotskaya, L.L.; Bogdan, O.P.; Manukchina, E.E.; Jdanov, V.V.; Sharova, N.K. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents. Antiviral Res. 1999, 41, 135-144.
6. El-Emam, A.A.; Al-Deeb, O.A.; Al-Omar, M.A.; Lehmann, J. Synthesis, antimicrobial, and antiHIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1adamantyl)-3-substituted aminomethyl-1,3,4- oxadiazoline-2-thiones. Bioorg. Med. Chem. 2004, 12, 5107-5113.
7. Balzarini, J.; Orzeszko, B.; Mauri, J.K.; Orzeszko, A. Synthesis and anti-HIV studies of 2adamantyl-substituted thiazolidin-4-ones. Eur. J. Med. Chem. 2007, 42, 993-1003. (Pubitemid 46907342)
8. Abou-Gharbia, M.A.; Childers, W.E., Jr.; Fletcher, H.; McGaughey, G.; Patel, U.; Webb, M.B.; Yardley, J.; Andree, T.; Boast, C.; Kucharik, R.J., Jr., Marquis, K.; Morris, H.; Scerni, R.; Moyer, J.A. Synthesis and SAR of adatanserin: novel adamantly aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents. J. Med. Chem. 1999, 42, 5077-5094. (Pubitemid 30020259)
9. Skolimowski, J.; Kochman, A.; G ȩbicka, L.; Metodiewa, D. Synthesis and antioxidant activity evaluation of novel antiparkinsonian agents, adamantane derivatives of nitroxyl free radical. Bioorg. Med. Chem. 2003, 11, 3529-3539. (Pubitemid 36870991)
10. Owen, J.C.E.; Whitton, P.S. Effect of amantadine and budipune on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats. Brain Res. 2006, 1117, 206-212.
11. El-Emam, A.A. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Chin. Pharm. J. 1990, 42, 309-315.
12. Wang, J.J.; Wang, S.S.; Lee, C.F.; Chung, M.A.; Chern, Y.T. In vitro antitumor and antimicrobial activity of N-substituents of maliemide by adamantane and diamantane. Chemotherapy 1997, 43, 182-189.
13. Orzeszko, A., Kamińska B.; Starościak, B.J. Synthesis and antimicrobial activity of new adamantane derivatives III. II Farmaco 2002, 57, 619-624. (Pubitemid 34876987)
14. Al-Deeb, O.A.; Al-Omar, M.A.; El-Brollosy, N.R.; Habib, E.E.; Ibrahim, T.M.; El-Emam, A.A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-[3-(1-adamantyl)-4substituted-5-thioxo-1,2,4-triazolin-1-yl]acetic acids, 2-[3-(1-adamantyl)-4-substituted-5-thioxo1,2,4-triazolin-1-yl]propionic acids and related derivatives. Arzneim.-Forsch./Drug Res. 2006, 56, 40-47.
15. Kadi, A.A.; El-Brollosy, N.R.; Al-Deeb, O.A.; Habib, E.E.; Ibrahim, T.M.; El-Emam, A.A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted1,3,4-oxadiazoles and 2-(1-adamantylamino)-5- substituted-1,3,4-thiadiazoles. Eur. J. Med. Chem. 2007, 42, 235-242.
16. El-Emam, A.A.; Ibrahim, T.M. Synthesis, anti-inflammatory and analgesic activity of certain 3(1-adamantyl)-4-substituted-5-mercapto-1,2,4-triazole derivatives. Arzneim.-Forsch./Drug Res. 1991, 41, 1260-1264.
17. Baxter, A.; Bent, J.; Bowers, K.; Braddock, M.; Brough, S.; Fagura, M.; Lawson, M.; McInally, T.; Mortimore, M.; Robertson, M.; Weaver, R.; Webborn, B. Hit-to-lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists. Bioorg. Med. Chem. Lett. 2003, 13, 4047-4050. (Pubitemid 37338445)
18. Antoniadou-Vyza, E.; Avramidis, N.; Kourounakis, A.; Hadjipetrou, L. Anti-inflammatory properties of new adamantane derivatives. Design, synthesis, and biological evaluation. Arch. Pharm. 1999, 331, 72-78.
19. Tehranchian, S.; Akbarzadeh, T.; Fazeli, M.R.; Jamalfar, H.; Shafiee, A. Synthesis and antibacterial activity of 1-[1,2,4-Triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7dihydrobenzo[c]thiophen-4(5H)ones. Bioorg. Med. Chem. Lett. 2005, 15, 1023-1025. (Pubitemid 40458642)
20. Turan-Zitouni, G.; Kaplancikli, Z.A.; Yildiz, M.T.; Chevallet, P.; Kaya, D. Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1- phenoxyethyl)-3-[N-(2thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives. Eur. J. Med. Chem. 2005, 40, 607-613. (Pubitemid 40732529)
21. Padmavathi, V.; Sudhakar Reddy, G.; Padmaja, A.; Kondaiah, P.; Ali-Shazia. Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur. J. Med. Chem. 2009, 44, 2106-2116.
22. Tozkoparan, B.; Küpeli, E.; Ye şilada, E.; Ertan, M. Preparation of 5-aryl-3-alkylthio-l,2,4triazoles and corresponding sulfones with antiinflammatory-analgesic activity. Bioorg. Med. Chem. 2007, 15, 1808-1814. (Pubitemid 46394040)
23. Labanauskas, L.; Udrenaite, E.; Gaidelis, P.; Brukštus, A. Synthesis of 5-(2,3,4-methoxyphenyl)4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity. II Farmaco 2004, 59, 255-259. (Pubitemid 38471918)
24. Navidpour, L.; Shafaroodi, H.; Abdi, K.; Amini, M.; Ghahremani, M.H.; Dehpour, A.R.; Shafiee, A. Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4triazoles as selective COX-2 inhibitors. Bioorg. Med. Chem. 2006, 14, 2507-2517. (Pubitemid 43343637)
25. Maxwell, J.R.; Wasdahl, D.A.; Wolfson, A.C.; Stenberg, V.I. Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and anti-inflammatory agents. J. Med. Chem. 1984, 27, 1565-1570.
26. Bayrak, H.; Demirbas, A.; Karaoglu, S.A.; Demirbas, N. Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities. Eur. J. Med. Chem. 2009, 44, 1057-1066.
27. Ashok, M.; Holla, B.S.; Boojary, B. Convenient one pot synthesis and antimicrobial evaluation of some new Mannich bases carrying 4-methylthiobenzyl moiety. Eur. J. Med. Chem. 2007, 42, 1095-1101. (Pubitemid 47082528)
28. Karthikeyan, M.S.; Prasad, D.J.; Boojary, B.; Bhat, K.S.; Holla, B.S.; Kumari, N.S. Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorphenyl moiety. Bioorg. Med. Chem. 2006, 14, 7482-7489.
29. El-Emam, A.A.; Moustafa, M.A.; Abdelal, A.M.; El-Ashmawy, M.B. Triazoles and Fused Triazoles IV: Synthesis of 3-(1-adamantyl)-6-substituted-s-triazolo[3, 4-b][1,3,4]thiadiazoles and 3-(1-adamantyl)-6-aryl-7H-s-triazolo[3,4-b][1,3,4] thia-diazines as potential chemotherapeutic Agents. Chin. Pharm. J. 1993, 45, 101-107.
30. Murray, P.R.; Baron, E.J.; Pfaller, M.A.; Tenover, F.C.; Yolken, R.H. Manual of Clinical Microbiology; Wood, G.L., Washington, J.A., Eds.; Am. Soc. Microbiol.: Washington, D.C., USA, 1995.
31. Mai, A.; Artico, M.; Sbardella, G.; Massa, A.; Novellino, E.; Greco, G.; Loi, A.G.; Tramontano, E.; Marongiu, M.E.; La Colla, P. 5-Alkyl-2-(alkylthio)-6- (2,6-dihalophenylmethyl)-3,4dihydropyrimidin-4(H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives. J. Med. Chem. 1999, 42, 619-627. (Pubitemid 29110778)
32. Sahlberg, C.; Noreen, R.; Engelhardt, P.; Högberg, M.; Kangasmetsä, J.; Vrang, L.; Zhang, H. Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent nonnucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 1511-1516. (Pubitemid 28281415)
33. Sudbeck, E.A.; Massa, S.; Vig, R.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Uckun, F.M. Structure-based design of novel dihydroalkoxy-benzyloxypyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother. 1998, 42, 3225-3233. (Pubitemid 28553745)
34. National Committee for Clinical Laboratory Standards (NCCLS) Approved standard document M7A, Villanova, PA, USA, 1985.
35. Winter, C.A.; Risely, E.A.; Nuss, G.W. Carrageenin-induced paw oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
36. Roche, D.; Carniato, D.; Leriche, C.; Lepifre, F.; Christmann-Franck, S.; Graedler, U.; Charon, C.; Bozec, S.; Doare, L.; Schmidlin, F.; Lecomte, M.; Valeur, E. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorg. Med. Chem. Lett. 2009, 19, 2674-2678.
37. Chapman, K.E.; Coutinho, A.E.; Gray, M.; Gilmour, J.S.; Savill, J.S.; Seckl, J.R. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol. Cell. Endocrinol. 2009, 301, 123-131.